Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Cisplatin Plus Gemcitabine in Resectable Cholangiocellular Carcinoma
NCT01073839Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Aug 2008
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, gemcitabine in cholangiocarcinoma (CCA), sponsored by University of Zurich. Started Aug 2008; status: completed.
02
Drugs
cisplatingemcitabine
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT01073839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01073839.